An anti-CTLA-4 heavy chain-only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile.
Proc Natl Acad Sci U S A
; 119(32): e2200879119, 2022 08 09.
Article
in En
| MEDLINE
| ID: mdl-35925889
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoglobulin Heavy Chains
/
T-Lymphocytes, Regulatory
/
Immunotherapy
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2022
Type:
Article
Affiliation country:
China